Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2738_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
29 Мб
Скачать
Indications
https://t.me/med1917
Relieve ischaemic rest pain (where surgical Tx ineffective)
Limb condition threatening life (gas gangrene / severe infec tion)
Trauma (causing non-functionable limb)
Chapter 14: Vascular disease 185
Outcome:
30d mortality 15%
5y mortality 65%
Level of amputation
Most often digital (toe) or trans-metatarsal amputation secondary to diabetic foot sepsis Aim to establish arterial flow into foot to allow resultant wound to heal
Below knee (trans-tibial)* = greater functional success than above knee but
requires well-perfused calf
Above knee (trans-femoral)
Through knee amputation
Hip disarticulation
Hind-quarter amputation
*not if fixed flexion deformity of knee or severe OA
Rehabilitation
Pre-amputation consultation with physiotherapist and occupational therapist
Establish if patient will be able to use prosthesis
Is home suitable for wheelchair use? (all patients are discharged in a
wheelchair)
50% of diabetics with major limb amputation will have contralateral leg amputated in 2–3y
It requires 15% more energy to walk with a below-knee prosthesis & >20% more energy with an above-knee prosthesis
Initial exercises to prevent knee flexion deformity and muscle strengthening exercises
Practise transferring and wheelchair mobility
Consider use of pneumatic post-amputation mobility (PPAM) aid from 1w
Once wound has healed, prosthetic measurements commence at 6–8w
Complications of amputation
Early Late
Wound dehiscence
Infection
Contractures
Phantom limb pain
Surgery
186 Chapter 14: Vascular disease
https://t.me/med1917
Pathophysiology
Arterial spasm reduced perfusion ischaemia necrosis
Types
Persistent diffuse cyanosis of hands & feet
Persistent mottled cyanosis of skin e.g. APS, SLE, polycythaemia
Raynaud’s syndrome affects 5% of the population
Features suggesting 2° disease:
presentation in early childhood or >30y
asymmetrical distribution
male
= peripheral ischaemia associated with
smoking
Intermittent cyanosis of hands/feet and digits
Raynaud’s syndrome
condition
Autoimmune: scleroderma, SLE, RA, Sjögren’s,
dermatomyositis
Arterial disease: atherosclerosis, thoracic outlet obstruction, Buergers disease
Endocrine: DM, hypothyroidism
Blood: lymphoma, polycythaemia
Environmental: smoking, trauma, chemicals, chronic vibration
Drugs: beta-blockers, COCP, cytotoxic agents
burning on rewarming
PALE
(ischaemia)
BLUE
(cyanosis)
RED (reactive
hyperaemia)
Must screen for these O/E & with blood tests
Triggers:
cold emotion smoking exercise
Fig. 14.4 Raynaud’s syndrome.
Surgery
1. Hx & examination
2. Bloods: FBC, U&Es, LFT, TFT, coag, glucose
3. Autoimmune screen: ANA, CRP
Refer to rheumatology / other specialty if suspect underlying cause
Lifestyle: stop smoking, warm clothing / avoid cold & other triggers (e.g. COCP/BBs)
± Vasodilators: CCBs (nifedipine)
IV Prostaglandins: iloprost ± Surgery = last resort (sympathectomy, embolectomy)
compression of neurovascular bundle within thoracic outlet
https://t.me/med1917
Causes
Cervical rib
Healed clavicular fracture
Scalene muscle hypertrophy
Malignancy (Pancoast tumour)
Clinical presentation
Venous: DVT & peripheral swelling
Arterial: claudication / limb ischaemia
Neuro: pain, paraesthesia, weakness, muscle wasting T1 distribution
Investigations
Chapter 14: Vascular disease 187
DDx: cervical myelopathy
1. Hx & examination
2. Bloods: FBC, clotting
3. CXR – show cervical ribs
4. Duplex USS – dynamic vascular compression
5. Nerve conduction studies
6. MRI – with arms fully abducted
Management
Venous: thrombolysis ± venoplasty / surgical decompression Arterial: surgical decompression ± angioplasty/bypass Neurological: physio & Botox ± surgical decompression
Surgery
188 Chapter 14: Vascular disease
https://t.me/med1917
Cephalic
Med cub
SCV
Axillary
Brachial
Basilic
UlnarRadial
Femoral
Popliteal
Small saphenous
ILIAC
Sapheno– femoral junction
Mid-thigh perforator
Great saphenous
Pathophysiology of venous disease
Venous return driven by:
1. Muscle contraction
2. Intrathoracic pressure with inspiration
Blood flow = superficial perforating deep veins
Valves prevent BACKFLOW (absent in vena cava & common iliacs)
In deep veins = deep venous insufficiency (usually after DVT)
In superficial veins = VARICOSE VEINS
Upper limb
Deep
Lower limb
Superficial
Fig. 14.5 Venous systems of the upper
& lower limbs.
*Thrombophlebitis without suspicion of DVT is treated with topical NSAIDs only
Classifying symptoms:
CEAP classification: Clinical, aEtiological, Anatomical, Pathophysiological
Venous Clinical Severity Score (VCSS)
Indications for NHS Tx:
Denition
Primary: idiopathic or no valve defect (women, pregnancy) Secondary: to deep venous insufficiency
(DVT or pelvic pressure)
Clinical presentation
Cosmetic
May be itchy (venous eczema)
May cause heaviness/aching & ankle oedema
Venous ulceration
Complications
Thrombophlebitis: inflamed vein due to clot red, painful, hot
Tx: topical NSAIDs* or LMWH (if >5cm and within 3–5cm of SFJ)
Bleeding: due to skin thinning (most often after a hot shower)
Immediate Tx: elevation + compression
Venous ulcers: 50% caused by varicose veins
Venous eczema: red & flaky skin
Lipodermatosclerosis: brown haemosiderin ‘champagne bottle’
Recurrent thrombophlebitisVenous ulcers Bleeding Chronic skin changes
(eczema/lipodermatosclerosis)
Signs of chronic venous insufficiency:
Surgery
Diagnosis
Duplex USS
Management
1. Lifestyle: weight loss, exercise, avoid prolonged standing
2. Compression stockings: must r/o PAD first with ABPI (>0.8)
3. Endothermal catheter ablation: radiofrequency catheter passed up great
saphenous vein to heat vein & seal it
4. Foam sclerotherapy: inject foam containing sclerosing agent into vein to
sealvein
5. Surgery: disconnect great saphenous vein and strip it out
13
NICE (2013) Varicose veins [CG168]
13
Chapter 14: Vascular disease 189
https://t.me/med1917
Venous (70%) Arterial Neuropathic
Pathophysiology Valve incompetence & reflux
Calf muscle dysfunction
= toxins accumulate inflammation and necrosis
Risk factors DVT, varicose veins, age, pregnancy,
surgery
Location Gaiter area
(between malleolus and knee)
Features Large and irregular
Shallow with sloping edges
Granulation tissue
= may be painful
Leg condition Lipodermatosclerosis
Venous eczema
Haemosiderin (red/brown)
Atrophie blanche
(smooth white sclerotic plaques)
Heavy, aching, pruritus, oedema
Atheromatous changes =
compromised blood flow
= hypoxia & toxins accumulate inflammation and necrosis
Diabetes, HTN, smoking, arterial disease, cholesterol emboli, Raynaud’s disease, trauma
Bony prominences
(lateral malleolus and toes)
Smaller and round
‘Punched-out’ borders
Little granulation tissue
& dry
= very painful
Claudication / ischaemic rest pain symptoms
Cool, hairless, dry, shiny skin
Peripheral neuropathy
Vascular disease & infection
Diabetes, trauma, prolonged pressure, alcohol excess, B12/folate deficiency
Pressure areas
Small, round, deep
‘Punched-out’ borders
Thick rim
Surrounding callus
Loss of sensation
Dry, cracked skin
Specific treatment
General treatment
Fig. 14.6
Elevation and compression
1st-line: 4-layer bandaging Other: stockings
Superficial venous surgery
(prevents recurrence and accelerates healing)
Must exclude coexisting arterial insufficiency before starting compression therapy (with ABPI)
Dressings ± antibiotics ± emollients
Debridement: dressings, surgery, larvae
Fig. 14.7 Fig. 14.8
Manage vascular risk factors
e.g. antiplatelets, stop smoking
Surgical revascularisation
(to restore vascular flow)
Optimise glycaemic control
Treat coexisting arterial disease
Good foot care
X-ray/MRI to find osteomyelitis
Offload pressure
Surgery
190 Chapter 14: Vascular disease
https://t.me/med1917
All patients have VTE risk assessment on admission
prophylactic LMWH if indicated
Differentials of DVT:
Cellulitis: ± rash/pus Chronic venous insufficiency: chronic skin
change signs
Superficial thrombophlebitis: erythema/
inflammation along vein
Acute arterial ischaemia: pallor, pain,
pulseless, etc.
Baker’s cyst: swelling behind knee & knee
stiffness
Wells score for DVT:
Clinical features Points
Active cancer (including current Tx or
1
Tx in past 6m)
Paralysis / paresis / plaster
1
immobilisation of lower limb
Bedridden ≥3d or major surgery in
1
past 12w
Localised tenderness along deep
1
venous system
Entire leg swollen 1
Calf swelling ≥3cm larger than
1
other leg
Pitting oedema confined to
1
symptomatic leg
Collateral superficial veins
1
(non-varicose)
Previous DVT 1
Alternative diagnosis at least as
–2
likely as DVT
If suspicion of DVT/PE, start treatment dose LMWH while waiting for scan results to confirm or r/o
Risk factors
1. Blood stasis: immobility, surgery, varicose veins, long-haul travel
2. Hypercoagulability: obesity, pregnancy, dehydration, OCP, thrombophilia,
infection, malignancy, IVDU
3. Endothelial damage: age, trauma/surgery (especially orthopaedic)
Deep vein thrombosis (DVT)
Unilateral symptoms:
Leg tenderness, warmth, swelling, erythema
Pitting oedema
Distended superficial
veins / thrombophlebitis
1. Wells score: determines next step
2. d-dimer: not specific for DVT/PE
3. Compression USS: if no
compression = clot
4. Duplex USS: shows clot
Low risk
Score <2
d-dimer Urgent USS
−ve
Urgent USS
−ve
Calculate Wells score
Mod–high risk
Score ≥2
+ve +ve
+ve
−ve
−ve
d-dimer
Anti-
coagulate
+ve
Anti-
Fig. 14.9
coagulate
Pulmonary embolism (PE)
Acute onset SOB
Pleuritic pain
Haemoptysis
O/E: tachycardia, hypotension, low-grade fever, JVP, signs of DVT
Differentials of PE:
MI/angina COPD/asthma exacerbation Pneumonia Pneumothorax CHF Cardiac tamponade
Surgery
1. Wells score: determines next step
<4 = d-dimer (if +ve = urgent CTPA)>4 = Urgent CTPA (V/Q scan if CTPA contraindicated)
2. Bloods: FBC, LFTs, U&Es, clotting, ABG
3. CXR: usually normal
4. ECG: sinus tachycardia (S1Q3T3)
5. Echo: may be considered to look for right heart strain
14
NICE (2020) Venous thromboembolic diseases [NG158]
Categorisation of PE:
https://t.me/med1917
Chapter 14: Vascular disease 191
1. Massive (5%): >50% pulmonary circulation blocked
chest pain, severe SOB, hypotension & hypoxia
2. Major (10%): mid-sized pulm arteries blocked
chest pain, SOB, haemoptysis
3. Minor (85%): small peripheral vessels blocked
may be asymptomatic, SOB
(no ECG changes)
4. Subacute: multiple small/medium
emboli accumulate
over weeks = JVP, cor pulmonale
(ECG = RV strain)
Management of thromboembolic disease
, fluids, analgesia
2
1st-line: DOAC (apixaban/rivaroxaban) Alternative: LMWH (until INR in range) then warfarin
(if unprovoked event / high risk = continue 6m)
NB: thrombolysis (alteplase) only indicated if of cardiac arrest
massive
PE / resistant to fluid resuscitation / at risk
15
If high risk of PE & CTPA not immediately available, then start anticoagulation
(don’t wait for CTPA confirmation)
If anticoagulation is contraindicated, or recurrent VTE despite anticoagulation, consider an IVC filter
Bloods: FBC, U&Es, LFT, clotting, coag screen (APTT/PT)
Antiphospholipid antibodies: APS
Cancer screen: bloods, urinalysis, CXR, PSA/mammogram
CT scan: may show iliac artery compression
NB: if features suggesting cancer = immediate CT CAP
of cancer)
(if not do bloods first, then CT CAP if concern
CT venogram + referral to vascular surgery
Consideration of catheter-directed thrombolysis ± venous stenting
Compression of left iliac artery = MayThurner syndrome
15
NICE (2020) Venous thromboembolic diseases [NG158]
Surgery
192 Chapter 14: Vascular disease
https://t.me/med1917
Chronic swelling due to fluid in soft tissues as the result of failed lymphatic drainage
Aetiology
PRIMARY: due to inherited abnormality of lymphatic vessels (e.g. Milroy’s disease)
presents early in life
SECONDARY: due to obstruction of / damage to lymphatic vessels
infection/cellulitis trauma malignancy venous disease / DVT liver disease renal disease immobility/obesity heart failure cancer surgery / radiotherapy
Clinical presentation
Non-pitting oedema usually in legs & arms
Investigations
1. Careful Hx & examination measure circumference of limb
2. Lymphoscintigraphy radioactive dye injected into lymphatic system
Management
1. Compression bandages
2. Skin care ± ABX – reduce risk of cellulitis
3. Exercise/mobilisation
4. Specialised massage techniques
Surgery
protein
https://t.me/med1917
193
(TBvaccine)
lithotripsy
Score
tumour
194 Chapter 15: Urology
1%
Familial disorders affecting cystine transport in kidneys
https://t.me/med1917
Complications:
Pain, infection, sepsis, hydronephrosis & post‑renal AKI, obstructive uropathy
Clinical presentation
Acute: Loin groin pain, flank tenderness, palpable kidney, infection, haematuria Chronic: renal failure (oligo-/anuria)
Often restless / cannot keep still
Risk factors
1: renal pelvis
2: pelvic brim
3: VUJ
Fig. 15.1 Common sites of obstruction.
Common sites of obstruction = narrowings:
1. Renal pelvic–ureteric junction (PUJ)
2. Pelvic brim
3. Vesico‑ureteric junction (VUJ)
Differentials:
Gynaecology (e.g. ectopic, ovarian cyst etc.)
Pyelonephritis
Appendicitis
MSK pain
Bowel obstruction
Ruptured AAA
Biliary pathology
Dehydration
Diet (high protein, high salt)
FHx or PHx
Repeated UTIs
Endocrine disorders (Addison’s,
Cushing’s, hyperparathyroidism, hypercalciuria, cystinuria, gout)
80%
1
Calcium
Struvite
Uric acid
Cystine
Types of stone
7%
13%
Fig. 15.2
Clinical presentation
1. URETERIC COLIC: sudden onset loingroin pain (in waves)
2. Nausea & vomiting
cramping pain that comes in waves
Anatomical abnormalities
(horseshoe kidney, strictures, PUJ obstruction)
Drugs (steroids, chemotherapy, loop
diuretics)
40% Calcium oxalate 4% Calcium phosphate 36% Mixture
Magnesium, ammonium, phosphate (UTIs)
‘Staghorn calculi’
Radiolucent
Smell like sulphur
(metabolic)
3. Haematuria (often microscopic)
4. Concurrent infection: fever, rigors,
sepsis
Fig. 15.3
Indications for emergency intervention?
YES
1. Drain kidney: JJ Stent or nephrostomy
2. Treat the stone: ESWL/PCNL/ureteroscopy
Distal ureteric
stone
Conservative
ESWL
Rigid
ureteroscopy
Acute management:
ABCDE: fluids if NBM/vomiting
Analgesia: diclofenac, opiates, paracetamol
IV ABX: if signs of infection
Signs of infection
Renal impairment (AKI)
Kidney obstruction (hydronephrosis)
A single functioning kidney
Proximal ureteric
stone
ESWL
Rigid
ureteroscopy
Conservative
Surgery
NO
Renal stone
ESWL
PCNL
Flexi-
ureteroscopy
Active surveillance
Investigations
1. Hx & examination: renal angle tenderness
2. Urine dip & MCS – for infection, urine pH & haematuria
3. Bloods:
FBC, CRP/ESR, clotting, VBG (metabolic acidosis)
U&Es (Cr suggests AKI/dehydration)
Ca, PO4, urate, glucose
4. Basic imaging: non-contrast CT KUB = gold standard for stone visualisation
5. Specialist imaging: CT urogram (only if urology request)
Management options
Conservative: 80% stones pass on
2,3
PCNL (percutaneous nephrolithotomy): nephroscope into
scan 2–3w, medical expulsive therapy,
safety-netting
ESWL (extra-corporeal shock wave lithotripsy): US waves break up stone
so it can pass spontaneously
1
Alelign T, Petros B (2018) Kidney stone disease: an update on current concepts. Adv Urol,
2018:3068365.
2
NICE (2019) Renal and ureteric stones [NG118]
3
European Society of Urology (2021) Guidelines on urolithiasis
renal pelvis + lithotripsy to fragment stone
Ureteroscopy + stone fragmentation:
endoscope up urethra & ureter, then stone lithotripsy & removal
*** PREGNANCY TEST IF WOMAN OF CHILD­BEARING AGE ***